Rainbow Childrens Medicare Ltd
Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers a wide range of services such as newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care, obstetrics, and gynecology. [1] It is country’s largest pediatric hospital chain with 16 hospitals spread across 6 cities.[2]
Strengths
- +Company's median sales growth is 24.3% of last 10 years
- +Company's working capital requirements have reduced from 47.7 days to 19.5 days
Weaknesses
- −Stock is trading at 8.60 times its book value
Shareholding Pattern
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 49.87% | 49.85%▼0.0 | 49.85% | 49.85% | 49.85% | 49.85% | 49.84%▼0.0 | 49.84% |
| FIIs | 24.78% | 25.12%▲0.3 | 25.12% | 23.69%▼1.4 | 23.6%▼0.1 | 21.85%▼1.8 | 19.24%▼2.6 | 17.24%▼2.0 |
| DIIs | 13.81% | 13.84%▲0.0 | 13.87%▲0.0 | 15.31%▲1.4 | 15.44%▲0.1 | 17.46%▲2.0 | 19.49%▲2.0 | 21.12%▲1.6 |
| Public | 11.53% | 11.2%▼0.3 | 11.16%▼0.0 | 11.14%▼0.0 | 11.11%▼0.0 | 10.82%▼0.3 | 11.4%▲0.6 | 11.68%▲0.3 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 319 | 322 | 326 | 315 | 404 | 382 | 354 | 335 | 408 | 394 |
| Expenses | 204 | 208 | 223 | 225 | 260 | 251 | 243 | 235 | 268 | 264 |
| Operating Profit | 114 | 114 | 103 | 90 | 143 | 130 | 111 | 100 | 141 | 131 |
| OPM % | 36% | 35% | 32% | 29% | 36% | 34% | 31% | 30% | 34% | 33% |
| Net Profit | 64 | 61 | 50 | 39 | 77 | 67 | 55 | 52 | 73 | 66 |
| EPS ₹ | 6.3 | 6.02 | 4.97 | 3.82 | 7.62 | 6.6 | 5.37 | 5.09 | 7.2 | 6.48 |
AI Insights
TTM revenue at ₹1,492Cr, up 2.5% YoY. OPM at 32%.
Borrowings at ₹727Cr. Debt-to-equity ratio: 0.49x. Healthy balance sheet.
CWIP at ₹52Cr (4% of fixed assets). Moderate ongoing capital expenditure.
DIIs: 21.12% (+5.76pp change). FIIs: 17.24% (-2.96pp change). Promoters hold 49.84%.
ROCE improving from 0% (Mar 2015) to 18% (Mar 2025). Working capital days: 19.
PE 55.9x with 18.3% ROCE. Price is 766% above book value of ₹156. Dividend yield: 0.22%.
Recent Announcements
- Compliances-Reg.24(A)-Annual Secretarial Compliance 1d - Annual Secretarial Compliance Report for FY2025-26 filed under Regulation 24A.
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 2d - Conference call for declaration of financial results for the quarter and financial year ended March 31, 2026.
- Board Meeting Intimation for Approval Of Audited Financial Results (Standalone And Consolidated), AGM, Dividend And Other Matters. 2d - Board meeting on May 23, 2026 to approve FY26 results and consider final dividend.
- Update On Ongoing Tax Litigation 8 May - GST appeal against May 29, 2024 demand disallowed; company plans further appeal.
- Commencement Of New Spoke Hospital In HRBR Layout, Hennur And Mahadevpura IVF Centre. 4 May - Rainbow opened a 60-bed HRBR hospital and Mahadevapura IVF centre on May 4, 2026; ₹52 crore capex.
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse